0001209191-22-009417.txt : 20220214
0001209191-22-009417.hdr.sgml : 20220214
20220214172817
ACCESSION NUMBER: 0001209191-22-009417
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220103
FILED AS OF DATE: 20220214
DATE AS OF CHANGE: 20220214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jakobovits Aya
CENTRAL INDEX KEY: 0001823901
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38359
FILM NUMBER: 22635193
MAIL ADDRESS:
STREET 1: 3135 HUTTON DRIVE
CITY: BEVERLY HILLS
STATE: CA
ZIP: 90210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adicet Bio, Inc.
CENTRAL INDEX KEY: 0001720580
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813305277
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 CLARENDON STREET
STREET 2: FLOOR 6
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-482-2333
MAIL ADDRESS:
STREET 1: 200 CLARENDON STREET
STREET 2: FLOOR 6
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: resTORbio, Inc.
DATE OF NAME CHANGE: 20171024
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-03
0
0001720580
Adicet Bio, Inc.
ACET
0001823901
Jakobovits Aya
C/O ADICET BIO, INC.
200 CLARENDON STREET, FLOOR 6
BOSTON
MA
02116
1
0
0
0
Common Stock
2022-01-03
4
S
0
6000
18.0208
D
366343
I
See Footnote
Common Stock
2022-01-03
4
S
0
6000
18.0218
D
366345
I
See Footnote
Common Stock
2022-01-05
4
S
0
2000
16.932
D
364343
I
See Footnote
Common Stock
2022-01-05
4
S
0
2000
16.8995
D
364345
I
See Footnote
Common Stock
2022-02-09
4
S
0
4000
14.0294
D
360343
I
See Footnote
Common Stock
2022-02-09
4
S
0
4000
14.0303
D
360345
I
See Footnote
Common Stock
138076
I
See Footnote
These sales were effected pursuant to Rule 10b5-1 trading plans previously adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.11. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Shares held in a trust of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits' daughter is the beneficiary.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.07. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Shares held in a trust of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits' son is the beneficiary.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.41 to $17.38. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.41 to $17.21. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.26. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.26. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Shares held in a revocable trust of which Dr. Jakobovits and her spouse are co-trustees.
/s/ Nick Harvey, Attorney-in-Fact for Aya Jakobovits
2022-02-14